Searched for
IRBESARTAN TABLETS
Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...- Fresh tailwinds emerge as government comes in again with intent: 7 pharma stocks with upside potential of up to 36%Budget 2026 underlines the government’s intent – in terms of the sectors it will focus on. Now, it is not all of a sudden that the governme...
- It was true in 2008, will be true in 2026, and even in 2036: Hold good stocks for wealth creation; 10 stocks that fit the billThere is enough evidence to show that it is by holding on to stocks for the long term that you ensure wealth creation. Anything can happen ...
- ‘Hold’ a good business & wealth creation will happen: 16 large & mid-cap stocks for investors with an ability to ignore noiseLast week, although the Nifty touched an all-time high, there was considerable turbulence. And the broader market is not in alignment with ...
- Pharma stocks: Moving from ‘What if’ to ‘Maybe not’. 8 pharma stocks, 3 with upside potential above 22%; others not so high, but…There are two ways to look at the hope which the street is reflecting when it comes to a possible India-US tariff deal. One, it will bring ...
- One simple reason to own & trade them: 5 large-caps from different sectors with upside potential of up to 46%The rising stock price of a company does not mean that the business is strong. And a falling stock price does not mean that the business is...
- Wealth creation is about holding the right stocks and ignoring the noise. 13 ‘right stocks’ with an upside potential of up to 34%Here’s an exercise for investors who entered the markets post-March 2020 (or, even post-2014): Google search (or ask ChatGPT) to list event...
- Pharma stocks: With headwinds of uncertainty over, will they outperform? 7 stocks with an upside potential of up to 43%When it is Trump, logic usually flies out of the window. There is, indeed, little that is logical about the reciprocal tariffs he has annou...
- It is not always about buying or selling; sometimes, just ‘hold’ stocks: 10 large-caps with an upside potential of up to 49%As the market recovers, what is the more difficult decision to make? To buy or sell stocks? No, the tougher call is which stock to hold on ...
- Pharma: Stay bullish, but hedge to avoid mistake of selling due to deadline. 7 stocks with upside potential of up to 50%While Democrats are better known to push for lower drug prices in the US, in recent times even Republicans are talking about keeping the co...
- Look for good quality businesses at relatively lower valuations: 5 large-caps from different sectors with upside potential of up to 44%Our headline says “relatively” lower valuations. Now, “relatively” is used in two contexts. A stock that was trading at a PE of 93 is today...
- Decline in rupee: Besides IT, there are other winners as well; 9 pharma stocks with an upside potential of up to 40%The relationship between a decline in the rupee and better margins for IT companies is well known. What is not discussed much is that pharm...
- Manufacturing issues led drug makers Glenmark, Sun Pharma, Dr Reddy's to recall products in USAs per the US health regulator, a class II recall is initiated in a situation in which use of, or exposure to, a violative product may caus...
- Aurobindo recalls hypertensive drug in US citing cancer riskScieGen Pharmaceuticals has initiated recall of the finished Irbesartan drug from the market, a separate notification by the FDA said.
- Unichem Lab gets USFDA nod for hypertension drugThe company has received final abbreviated new drug application (ANDA) approval from the US Food and Drug Administration (USFDA).
- Sensex advances 200 points; top 14 stocks in focusNifty also managed to gain over 50 points to reclaim its crucial psychological level of 8800, supported by gains in power, oil & gas, banks...
- Jubilant Life gets USFDA nod for hypertension, allergies drugsJubilant Life Sciences had a total of 781 filings for formulations of which 333 have been approved in various regions globally as on Decemb...
- Unichem Labs gets USFDA approval for hypertension drugIrbesartan tablets are indicated for the treatment of hypertension and are therapeutically equivalent to Sanofi Aventis' Avapro tablets, it...
- Lupin gets US FDA nod for generic Avapro tabletsPharma major Lupin today said its subsidiary, Lupin Pharmaceuticals, has received approval for its Irbesartan tablets from US Food and Drug...
- Zydus Cadila gets USFDA nod for hypertension drug Isbesartan tabletDrug firm Zydus Cadila has received the US health regulator's approval to market Isbesartan tablets, used in treating hypertension, in the ...
Load More
